Technology

Samsung Biologics, GreenLight to produce COVID vaccine for Africa

Samsung Biologics, GreenLight to produce COVID vaccine for Africa

Samsung Biologics and Boston-based biotech firm GreenLight Biosciences have teamed up to help make COVID-19 vaccines more accessible to people in poor countries, especially in Africa, the Korean pharmaceutical company said Thursday. Under a contract manufacturing deal signed earlier in the day, Samsung Biologics will produce drug substances for GreenLight’s messenger RNA COVID-19 vaccine candidate.

Click here to read more -->
×